...

Ibrutinib

Information about the Bruton tyrosine kinase (BTK) inhibitor ibrutinib (Imbruvica), commonly used in hematologic neoplasms.

How useful was this post?

Please, click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Share This Content:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending now

Evaluation of the Peripheral Blood Smear
Educational Resources for Hematology/Oncology Fellows
Hypercoagulability (Thrombophilia) Testing During Acute Thrombosis
Hypercoagulability (Thrombophilia) Testing While on Anticoagulation
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.